PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
NCT06486220
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
Intestinal bacteria freeze-dried powder capsules
Sponsor
Yun-fei Xia